Mitochondria are cellular organelles responsible for ATP (adenosine triphosphate) production through oxidative phosphorylation, generating the chemical energy powering all cellular processes. Mitochondrial dysfunction contributes to aging, metabolic disease, neurodegeneration, and cardiovascular pathology. Peptide research has identified compounds targeting mitochondrial function, enhancing ATP production, reducing oxidative stress, and restoring cellular bioenergetics in disease models.
Mitochondrial Structure and ATP Synthesis
Mitochondria contain two membranes: the outer mitochondrial membrane (OMM) and inner mitochondrial membrane (IMM). The IMM houses the electron transport chain (ETC) proteins and ATP synthase. During oxidative phosphorylation, electron donors (NADH, FADH2) from the citric acid cycle transfer electrons through four protein complexes (I-IV) in the ETC, pumping protons into the intermembrane space. This proton gradient drives ATP synthase to phosphorylate ADP into ATP, with oxygen as the final electron acceptor. This process generates approximately 30-36 ATP molecules per glucose molecule oxidized.
Cardiolipin and Mitochondrial Function
Cardiolipin is a unique lipid enriched in the inner mitochondrial membrane, comprising approximately 20% of IMM lipids. This anionic phospholipid plays structural roles in organizing ETC protein complexes, stabilizing cristae organization, and regulating apoptosis. SS-31 (elamipretide) specifically targets cardiolipin through its D-arginine and dimethyltyrosine residues, enhancing ETC protein complex assembly and function, improving ATP synthesis efficiency, and reducing ROS generation in aged or damaged mitochondria.
NAD+ Metabolism and Metabolic Regulation
NAD+ is an essential coenzyme for glycolysis, the citric acid cycle, and fatty acid oxidation—all critical for mitochondrial fuel utilization. NAD+-dependent sirtuins (SIRT1-7) regulate metabolic flexibility, mitochondrial biogenesis, autophagy, and stress resistance. 5-Amino-1MQ enhances NAD+ bioavailability by inhibiting NNMT, the enzyme catabolizing NAD+ to N-methylnicotinamide. This NAD+ preservation activates sirtuins and activates AMP-activated protein kinase (AMPK), enhancing mitochondrial function and metabolic adaptation to stress and nutrient availability.
References
Kagan, V. E., et al. (2015). Elamipretide stimulates dephosphorylation of bad and localizes predominantly to the inner mitochondrial membrane. Cell Death & Disease, 6(1), e1591. PMID: 25590797
Cantó, C., & Auwerx, J. (2012). NAD+ as a signaling molecule modulating mitochondrial function. Molecular Metabolism, 1(1), 34-38. PMID: 24024048
Spinazzi, M., Casarin, A., Pertegato, V., Salviati, L., & Angelini, C. (2012). Assessment of mitochondrial respiratory chain enzymatic activities on tissues and cultured cells. Nature Protocols, 7(6), 1235-1246. PMID: 22653156
